These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 37091809)

  • 61. Prognostic and immunotherapeutic predictive value of interleukin enhancer-binding factor 3 in hepatocellular carcinoma: Integrated bioinformatics and experimental analysis.
    Qiu J; Wu X; Luo Y; Yao Y; Zhang X; Pan B; Wang X; Tang N
    Gene; 2023 Mar; 856():147132. PubMed ID: 36566982
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pan-cancer Multi-omics Analysis Reveals HMGN1 as a Potential Prognostic and Immune Infiltration-associated Biomarker.
    Guo Y; Zhang R; Xu H; Hong K; Cen K; Mai Y; Wu Z
    Curr Med Chem; 2024 Jan; ():. PubMed ID: 38310387
    [TBL] [Abstract][Full Text] [Related]  

  • 63. KIF11 As a Potential Pan-Cancer Immunological Biomarker Encompassing the Disease Staging, Prognoses, Tumor Microenvironment, and Therapeutic Responses.
    Guo X; Zhou L; Wu Y; Li J
    Oxid Med Cell Longev; 2022; 2022():2764940. PubMed ID: 36742345
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Systematic analysis of the role of LDHs subtype in pan-cancer demonstrates the importance of LDHD in the prognosis of hepatocellular carcinoma patients.
    Wang S; Wu X; Wu X; Cheng J; Chen Q; Qi Z
    BMC Cancer; 2024 Jan; 24(1):156. PubMed ID: 38291366
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Pan-Cancer Analyses Reveal Oncogenic and Immunological Role of PLOD2.
    Xu Q; Kong N; Zhao Y; Wu Q; Wang X; Xun X; Gao P
    Front Genet; 2022; 13():864655. PubMed ID: 35586565
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pancancer Analysis of NSUN2 with a Focus on Prognostic and Immunological Roles in Endometrial Cancer.
    Zan Y; Ding Y
    Reprod Sci; 2024 Jun; ():. PubMed ID: 38900401
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Comprehensive Analysis of
    Liu J; Zhu B; Chen J; Cao Y
    Anticancer Res; 2023 Oct; 43(10):4491-4509. PubMed ID: 37772558
    [TBL] [Abstract][Full Text] [Related]  

  • 68. LncRNA ST7-AS1 is a Potential Novel Biomarker and Correlated With Immune Infiltrates for Breast Cancer.
    Zhang Z; Zhang H; Li D; Zhou X; Wang J; Zhang Q
    Front Mol Biosci; 2021; 8():604261. PubMed ID: 33912584
    [No Abstract]   [Full Text] [Related]  

  • 69. Pan-cancer analysis of CREB3L1 as biomarker in the prediction of prognosis and immunotherapeutic efficacy.
    Lin Z; Wu Y; Xiao X; Zhang X; Wan J; Zheng T; Chen H; Liu T; Tang X
    Front Genet; 2022; 13():938510. PubMed ID: 36171879
    [No Abstract]   [Full Text] [Related]  

  • 70. Systematic Pan-Cancer Analysis Identifies TREM2 as an Immunological and Prognostic Biomarker.
    Cheng X; Wang X; Nie K; Cheng L; Zhang Z; Hu Y; Peng W
    Front Immunol; 2021; 12():646523. PubMed ID: 33679809
    [TBL] [Abstract][Full Text] [Related]  

  • 71. CCL5 might be a prognostic biomarker and associated with immuno-therapeutic efficacy in cancers: A pan-cancer analysis.
    Huang Y; Wu L; Sun Y; Li J; Mao N; Yang Y; Zhao M; Ren S
    Heliyon; 2023 Jul; 9(7):e18215. PubMed ID: 37519664
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prognostic Values of METTL3 and Its Roles in Tumor Immune Microenvironment in Pan-Cancer.
    Guo Y; Heng Y; Chen H; Huang Q; Wu C; Tao L; Zhou L
    J Clin Med; 2022 Dec; 12(1):. PubMed ID: 36614956
    [No Abstract]   [Full Text] [Related]  

  • 73. Bioinformatic Analysis and Experimental Validation of HMGA2-AS1 as a Prognostic Biomarker Associated with Immune Infiltration in Gastric Cancer.
    Lyu G
    Recent Pat Anticancer Drug Discov; 2024 Apr; ():. PubMed ID: 38566377
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Comprehensive Analysis of RELL2 as a Potential Biomarker Associated with Tumor Immune Infiltrating Cells in a Pan-Cancer Analysis.
    Musha K; Ge X; Ablikim N; Lu B; Chen C; Huang J
    Dis Markers; 2022; 2022():5009512. PubMed ID: 35634441
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prognostic Significance and Immunological Role of FBXO5 in Human Cancers: A Systematic Pan-Cancer Analysis.
    Liu P; Wang X; Pan L; Han B; He Z
    Front Immunol; 2022; 13():901784. PubMed ID: 35720327
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Ferroptosis-related gene HIC1 in the prediction of the prognosis and immunotherapeutic efficacy with immunological activity.
    Wu Y; Lin Z; Tang X; Tong Z; Ji Y; Xu Y; Zhou Z; Yang J; Li Z; Liu T
    Front Immunol; 2023; 14():1182030. PubMed ID: 37388742
    [TBL] [Abstract][Full Text] [Related]  

  • 77. SAAL1, a novel oncogene, is associated with prognosis and immunotherapy in multiple types of cancer.
    Yang W; Han B; Chen Y; Geng F
    Aging (Albany NY); 2022 Aug; 14(15):6316-6337. PubMed ID: 35963646
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Systematic pan-cancer analysis identifies transmembrane protein 158 as a potential therapeutic, prognostic and immunological biomarker.
    Li J; Hou H; Sun J; Ding Z; Xu Y; Li G
    Funct Integr Genomics; 2023 Mar; 23(2):105. PubMed ID: 36977915
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A comprehensively prognostic and immunological analysis of actin-related protein 2/3 complex subunit 5 in pan-cancer and identification in hepatocellular carcinoma.
    Huang S; Sun L; Hou P; Liu K; Wu J
    Front Immunol; 2022; 13():944898. PubMed ID: 36148220
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Insights into the Oncogenic, Prognostic, and Immunological Role of BRIP1 in Pan-Cancer: A Comprehensive Data-Mining-Based Study.
    Liu Y; Wu X; Feng Y; Jiang Q; Zhang S; Wang Q; Yang A
    J Oncol; 2023; 2023():4104639. PubMed ID: 37153833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.